pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'nsclc', 'keynote 671', 'pembro', 'sclc', 'lcsm,(-blcsm)']
looking forward to hear the results of keynote 671, studying the use of pembrolizumab (an immune checkpoint inhibitor) in combination with chemo for #nsclc by #asco23 #lcsm
LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.